Target intelligence / Profile preview

Ubiquitin-associated and SH3 domain-containing protein A (UBASH3A)

Target
UBASH3A
Molecular classification
Protein tyrosine phosphatase (atypical type), Signaling adaptor protein, Other
01

Overview

UBASH3A encodes a signaling adaptor protein with ubiquitin-associated and SH3 domains that regulates cellular processes in the immune system, especially T-cell signaling. It negatively modulates receptor-mediated tyrosine kinase degradation, primarily acting via phosphatase-independent mechanisms, and is involved in controlling apoptosis and immune activation. The gene is mainly associated with immune regulation, and genetic variation or expression changes have been implicated in autoimmune diseases like type 1 diabetes and in certain cancers. UBASH3A functions largely by modulating receptor signaling, apoptosis pathways, and endocytic processes, and it can regulate various kinases and signaling molecules within lymphoid tissues. Key distinguishing facts: UBASH3A is not a conventional receptor, ion channel, or transporter, but instead a member of the atypical tyrosine phosphatase signaling adaptor family. It functions primarily in lymphoid tissues, affecting immune system development and regulation.

Other names
TULA-1T-cell ubiquitin ligand AUBS3AHGNC: 12462NCBI Gene: 53347UniProtKB: P57075
02

Mechanism of action

Drugs or molecules targeting UBASH3A would act via: Modulation of immune cell signaling (e.g., NF-κB pathway); Regulation of apoptosis in lymphocytes; Interference with receptor tyrosine kinase degradation.

03

Biological functions

Negative regulation of T-cell signalingRegulation of apoptosis (cell death) in T cellsModulation of receptor-type tyrosine kinase degradationRegulation of NF-κB signaling pathwayAccumulation of activated target receptors (including T-cell receptors, EGFR, PDGFRB)
04

Disease associations

Autoimmunity (notably type 1 diabetes)Cancer (neoplasms)Other immune-related diseases
05

Safety considerations

Targeting UBASH3A could alter immune cell signaling and apoptosis, potentially leading to immune dysregulation or increased risk of autoimmunity/cancerThe lack of strong phosphatase activity may pose challenges for direct enzymatic inhibition
06

Biomarkers

UBASH3A mutation levels as biomarkers for type 1 diabetes, autoimmunity, and certain cancersUBASH3A expression levels as biomarkers for type 1 diabetes, autoimmunity, and certain cancers

Beyond the preview

Go deeper on Ubiquitin-associated and SH3 domain-containing protein A (UBASH3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-associated and SH3 domain-containing protein A (UBASH3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call